$3,490,000 of PFIZER INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development HR 946 - ORPHAN Cures Act HR 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program HR 2214 - DRUG Act HR 2450 - Prescription Drug Transparency and Affordability Act PL 117-328 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Biosimilars Access, Reimbursement and Reform 340B Reform Prescription Drug User Fee Act (PDUFA) Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage and Access Intellectual Property Protections PBM Reform Cancer Policies Drug Pricing S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 946 - ORPHAN Cures Act HR 2450 - Prescription Drug Transparency and Affordability Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform Medicaid Prescription Drug Access Digital Therapeutics VICP Reform and Excise Tax Vaccine Injury Compensation Program International Supply Chain Global Access Tariffs Non-Tariff Trade Barriers"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 17 times in the past 6 months. Of those trades, 7 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/03.
- SENATOR RON WYDEN sold up to $15,000 on 06/03.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 05/30, 04/29, 02/26 and 2 sales worth up to $65,000 on 03/31, 01/24.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $100,000 on 05/15, 02/25 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/24 and 1 sale worth up to $50,000 on 04/11.
- REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 02/13.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFE Insider Trading Activity
PFE insiders have traded $PFE stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- RONALD E BLAYLOCK purchased 19,457 shares for an estimated $499,072
- JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PFE Hedge Fund Activity
We have seen 1,372 institutional investors add shares of PFE stock to their portfolio, and 1,399 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 107,429,526 shares (-69.1%) from their portfolio in Q1 2025, for an estimated $2,722,264,188
- WELLINGTON MANAGEMENT GROUP LLP removed 36,497,190 shares (-26.1%) from their portfolio in Q1 2025, for an estimated $924,838,794
- FISHER ASSET MANAGEMENT, LLC added 36,291,913 shares (+325.5%) to their portfolio in Q1 2025, for an estimated $919,637,075
- BLACKROCK, INC. added 22,427,541 shares (+5.0%) to their portfolio in Q1 2025, for an estimated $568,313,888
- PACER ADVISORS, INC. added 17,957,928 shares (+856.8%) to their portfolio in Q1 2025, for an estimated $455,053,895
- CAPITAL WORLD INVESTORS removed 16,386,931 shares (-37.6%) from their portfolio in Q1 2025, for an estimated $415,244,831
- AMUNDI added 15,758,846 shares (+43.4%) to their portfolio in Q1 2025, for an estimated $399,329,157
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFE Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 03/18/2025
To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 6 analysts offer price targets for $PFE in the last 6 months, with a median target of $26.5.
Here are some recent targets:
- Trung Huynh from UBS set a target price of $25.0 on 04/30/2025
- Carter Gould from Cantor Fitzgerald set a target price of $24.0 on 04/22/2025
- Asad Haider from Goldman Sachs set a target price of $25.0 on 04/08/2025
- Vamil Divan from Guggenheim set a target price of $33.0 on 02/10/2025
- Andrew Baum from Citigroup set a target price of $29.0 on 01/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
